Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1937 1
1940 1
1941 1
1945 3
1946 1
1947 4
1948 4
1950 4
1951 3
1952 4
1953 3
1954 3
1955 3
1956 1
1957 2
1958 2
1959 4
1960 3
1961 4
1962 2
1963 4
1964 11
1965 4
1966 2
1967 3
1968 1
1969 2
1970 8
1971 2
1972 6
1973 1
1974 6
1975 3
1976 3
1977 2
1978 4
1979 4
1980 4
1981 3
1982 2
1983 5
1984 8
1985 5
1986 6
1987 10
1988 8
1989 11
1990 4
1991 7
1992 8
1993 11
1994 17
1995 12
1996 15
1997 26
1998 22
1999 23
2000 21
2001 16
2002 16
2003 13
2004 23
2005 21
2006 34
2007 32
2008 38
2009 34
2010 44
2011 44
2012 33
2013 44
2014 33
2015 32
2016 24
2017 36
2018 28
2019 27
2020 32
2021 33
2022 29
2023 23
2024 31
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

994 results

Results by year

Filters applied: . Clear all
Page 1
Toxic Alcohol Poisoning.
Ross JA, Borek HA, Holstege CP, King JD. Ross JA, et al. Emerg Med Clin North Am. 2022 May;40(2):327-341. doi: 10.1016/j.emc.2022.01.012. Epub 2022 Apr 5. Emerg Med Clin North Am. 2022. PMID: 35461626 Review.
Pediatric Toxicology.
Ross JA, Eldridge DL. Ross JA, et al. Emerg Med Clin North Am. 2022 May;40(2):237-250. doi: 10.1016/j.emc.2022.01.004. Epub 2022 Apr 5. Emerg Med Clin North Am. 2022. PMID: 35461621 Review.
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Landgren O, Prior TJ, Masterson T, Heuck C, Bueno OF, Dash AB, Einsele H, Goldschmidt H, Knop S, Li C, Mellqvist UH, McFadden I, Oprea C, Ross JA, Talpes M, Hydren JR, Ahlstrom JM, Kazandjian D, Weinhold N, Zhang R, Stetler-Stevenson M, Marti G, Devlin SM. Landgren O, et al. Among authors: ross ja. Blood. 2024 Jul 25;144(4):359-367. doi: 10.1182/blood.2024024371. Blood. 2024. PMID: 38768337 Free PMC article.
HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.
Dickter JK, Aribi A, Cardoso AA, Gianella S, Gendzekhadze K, Li S, Feng Y, Chaillon A, Laird GM, Browning DL, Ross JA, Nanayakkara DD, Puing A, Stan R, Lai LL, Chang S, Kidambi TD, Thomas S, Al Malki MM, Nakamura R, Alvarnas J, Taplitz RA, Dadwal SS, Forman SJ, Zaia JA. Dickter JK, et al. Among authors: ross ja. N Engl J Med. 2024 Feb 15;390(7):669-671. doi: 10.1056/NEJMc2312556. N Engl J Med. 2024. PMID: 38354149 Free PMC article. No abstract available.
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
Place AE, Karol SE, Forlenza CJ, Cooper TM, Fraser C, Cario G, O'Brien MM, Gerber NU, Bourquin JP, Reinhardt D, Rubnitz JE, Opferman JT, Sunkersett G, Onishi M, Dunshee DR, Chen X, Unnebrink K, Vishwamitra D, Dunbar F, Badawi M, Ross JA, Loh ML. Place AE, et al. Among authors: ross ja. Pediatr Blood Cancer. 2025 Jun;72(6):e31630. doi: 10.1002/pbc.31630. Epub 2025 Mar 10. Pediatr Blood Cancer. 2025. PMID: 40062648 Clinical Trial.
Cancer cachexia.
Barber MD, Ross JA, Fearon KC. Barber MD, et al. Among authors: ross ja. Surg Oncol. 1999 Nov;8(3):133-41. doi: 10.1016/s0960-7404(99)00045-6. Surg Oncol. 1999. PMID: 11113664 Review.
Saturation diving; physiology and pathophysiology.
Brubakk AO, Ross JA, Thom SR. Brubakk AO, et al. Among authors: ross ja. Compr Physiol. 2014 Jul;4(3):1229-72. doi: 10.1002/cphy.c130048. Compr Physiol. 2014. PMID: 24944036 Review.
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study.
Kumar SK, Harrison SJ, Cavo M, de la Rubia J, Popat R, Gasparetto C, Hungria V, Salwender H, Suzuki K, Kim I, Onishi M, Ku G, Pothacamury R, Jalaluddin M, Zeng J, Ross JA, Dobkowska E, Moreau P. Kumar SK, et al. Among authors: ross ja. Lancet Haematol. 2025 Aug;12(8):e574-e587. doi: 10.1016/S2352-3026(25)00139-5. Epub 2025 Jun 27. Lancet Haematol. 2025. PMID: 40587991 Clinical Trial.
Heat-shock proteins and acute ischaemic kidney injury.
O'Neill S, Harrison EM, Ross JA, Wigmore SJ, Hughes J. O'Neill S, et al. Among authors: ross ja. Nephron Exp Nephrol. 2014;126(4):167-74. doi: 10.1159/000363323. Epub 2014 Jun 6. Nephron Exp Nephrol. 2014. PMID: 24923736 Review.
994 results